Placeholder Banner

#BIO2016 Keynote: A Look at the 2016 Presidential Election

June 8, 2016
Who will be the next president of the United States was the topic of Wednesday's keynote at the 2016 BIO International Convention in San Francisco. This year's unique panel of experts provided one of a kind insight into who will likely be the 2016 Presidential Election winner.

The esteemed panel of speakers included:

  • Candy Crowley, Award-Winning Journalist and Former Chief Political Correspondent for CNN

  • Stephanie Cutter, Top Political Strategist, Senior Advisor to President Obama and CNN Political Commentator

  • The Honorable Newt Gingrich, Distinguished World Leader, Powerful Visionary & Political Vanguard; 2012 Republican Presidential Candidate; Speaker of the U.S. House of Representatives (1995-1999)

The keynote was moderated by BIO President & CEO Jim Greenwood who began the conversation by asking the panel their thoughts on what will happen next now that Hilary Clinton has essentially clinched the Democratic nomination.

Candy Crowley argued that Bernie Sanders must fully grasp defeat. That while it's a grieving process, he must consider what is best for the Democratic party.

Stephanie Cutter followed up by saying that Sanders has tapped into a passion that Clinton hasn't been able to which will make it difficult for him to drop out of presidential race. When he meets with Sanders, President Obama will be blunt and stress the importance of this election year. She continued by stating that President Obama will most likely encourage Bernie Sanders to drop out of the race sooner than later.

This then begs the question of which candidate will Sanders' supporters rally behind? Cutter sees Sanders' supporters going to Hilary simply because Donald Trump has insulted and disparaged just about everyone .

Crowley believes that Sanders supporters may not vote at all or filter off to third party candidates. Voters may begin to ask themselves how can Trump do worse than the current administration. While every single metric is in Clinton's favor (according to Cutter), Crowley sees Clinton's inability to quantify her achievements as a potential driver of Sanders' supporters to vote for Trump.

Newt Gingrich stated that 75% of Americans view Washington, D.C. as corrupt. This may garner support for Donald Trump because Hilary Clinton has built a deep establishment within DC politics.  He argued that while Hilary may have the analytics to back her up, Trump was able to clinched the Republican nomination despite entering the presidential race extremely late in the game. If "he changes the American voter map then this will change the electoral map."

Who should the Candidates consider as potential running mates? Gingrich believes that Trump will have to find a Vice Presidential Candidate who share his ideological views. Someone who will complement his personality. Gingrich feels that Hilary Clinton should chose an African American or Hispanic running mate to keep the Democratic Party connected and to help it grow.

Crowley disagreed and feels that someone like Mark Warner would best be able to help Hilary in the purple states. She also thinks that Donald Trump would do best to find a running mate who has some experience in Washington politics.Stephanie Cutter argued that Hilary Clinton needs to pick someone with whom she has strong chemistry. She suggested Tim Caine or Duvall Patrick who also happens to support biotech.

Speaking of biotech...Greenwood concluded the keynote discussion by asking the panelists which candidate is better to help grow the industry. Gingrich and Crowley believe that Trump will come around to support biotech. He believes in strong patent rights, supports small businesses, and wants better trade practices with China. Trump would essentially be a better candidate for the biotech industry. Cutter stated that while Clinton recognizes the importance of the industry and understands the science, she needs to appeal to those Democrats who don't support large corporations and who have apprehensions about the benefits of biotech.